| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Environmental Health Sciences Division, National Institute for Environmental Studies, Tsukuba, Ibaraki 305-0053, Japan [B. Z., M. S., N. N., J. S. S., H. S., Y. A., C. T.], and Department of Toxicology, Institute of Environmental Medicine, School of Public Health, Beijing Medical University, Beijing 100083, China [B. Z.]
To investigate a possible involvement of metallothionein (MT) in chemical carcinogenesis, MT-I and MT-II gene-deficient [MT (-/-)] transgenic mice and wild-type [MT (+/+)] control mice were topically applied at a single dose of 100, 250, 500, or 1000 µg of 7,12-dimethylbenz[a]anthracene (DMBA) on the dorsal skin and thereafter compared. After 14 weeks of DMBA treatment, the skin tumor occurred in MT (-/-) mice only and in a dose-dependent manner, whereas no change was observed in MT (+/+) mouse skin given the same DMBA treatment. The tumor cells showed proliferative activity, as shown by proliferative cell nuclear antigen staining. These results demonstrate that MT acts as an endogenous defensive factor against DMBA-induced skin tumorigenesis.
1 This work was supported in part by Eco-Frontier Fellowship of Environmental Agency (to B. Z.).
2 To whom requests for reprints should be addressed.
Received 6/18/98. Accepted 7/28/98.
This article has been cited by other articles:
![]() |
J. S. Suzuki, N. Nishimura, B. Zhang, Y. Nakatsuru, S. Kobayashi, M. Satoh, and C. Tohyama Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice Carcinogenesis, June 1, 2003; 24(6): 1123 - 1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Long II, R. L. Waikel, X.-J. Wang, D. R. Roop, and A. K. Jaiswal NAD(P)H : quinone Oxidoreductase 1 Deficiency and Increased Susceptibility to 7,12-Dimethylbenz[a]-anthracene-Induced Carcinogenesis in Mouse Skin J Natl Cancer Inst, August 1, 2001; 93(15): 1166 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takaba, K. Saeki, K. Suzuki, H. Wanibuchi, and S. Fukushima Significant overexpression of metallothionein and cyclin D1 and apoptosis in the early process of rat urinary bladder carcinogenesis induced by treatment with N-butyl-N-(4-hydroxybutyl)nitrosamine or sodium L-ascorbate Carcinogenesis, April 1, 2000; 21(4): 691 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, Y. W. Ding, G.-y. Yang, F. Bondoc, M.-J. Lee, and C. S. Yang Oxidative damage in an esophageal adenocarcinoma model with rats Carcinogenesis, February 1, 2000; 21(2): 257 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kondo, S. Himeno, W. Endo, M. Mita, Y. Suzuki, K. Nemoto, M. Akimoto, J. S. Lazo, and N. Imura Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine in mice Carcinogenesis, August 1, 1999; 20(8): 1625 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Burczynski, H.-K. Lin, and T. M. Penning Isoform-specific Induction of a Human Aldo-Keto Reductase by Polycyclic Aromatic Hydrocarbons (PAHs), Electrophiles, and Oxidative Stress: Implications for the Alternative Pathway of PAH Activation Catalyzed by Human Dihydrodiol Dehydrogenase Cancer Res., February 1, 1999; 59(3): 607 - 614. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |